Cergentis
1 known investors
Cergentis provides genetic characterization and quality control services built on its Targeted Locus Amplification (TLA) technology platform, supporting the development of advanced therapies for pharma and biotech clients. Now part of Solvias, a CMC analytical services provider, it serves drug developers across the full development journey.